Insider Transactions

Date Name Title Type Shares Traded Price Range
Oct 25, 2019 Director, President and CEO Open market or private purchase of non-derivative or derivative security 15,000 $14.19
Oct 16, 2019 SVP and GM of Oncology Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,452 --
Oct 16, 2019 SVP/GM, Vascular Access Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,195 --
Oct 16, 2019 Director, President and CEO Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,139 --
Oct 16, 2019 EVP and CFO Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,320 --
Oct 16, 2019 SVP Global Operations and R&D Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,945 --
Oct 16, 2019 SVP and General Counsel Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,357 --
Aug 18, 2019 EVP and CFO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 826 $19.10
Aug 06, 2019 Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,581 $19.83
Aug 06, 2019 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,650 --
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.